Mon, May 23, 2022

Edward Tenthoff Maintained (STRO) at Buy with Decreased Target to $14 on, May 23rd, 2022

Edward Tenthoff of Piper Sandler, Maintained "Sutro Biopharma, Inc." (STRO) at Buy with Decreased Target from $29 to $14 on, May 23rd, 2022.

Edward has made no other calls on STRO in the last 4 months.



There is 1 other peer that has a rating on STRO. Out of the 1 peers that are also analyzing STRO, 0 agree with Edward's Rating of Hold.



This is the rating of the analyst that currently disagrees with Edward


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, May 11th, 2022